Clinical trial
The Individualized M(X) Drug-resistant TB Treatment Strategy Study A Strategy to Improve Treatment Outcomes in Patients With Drug-resistant TB
NCT03237182 is registered in ClinicalTrials.gov with Centre for the AIDS Programme of Research in South Africa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Individualized M(X) Drug-resistant TB Treatment Strategy Study A Strategy to Improve Treatment Outcomes in Patients With Drug-resistant TB
- Lead sponsor
- Centre for the AIDS Programme of Research in South Africa
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- June 14, 2017
- Completion date
- December 19, 2022
- Enrollment
- 205 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.